A detailed history of Virtus ETF Advisers LLC transactions in Compass Pathways PLC stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 13,281 shares of CMPS stock, worth $113,419. This represents 0.05% of its overall portfolio holdings.

Number of Shares
13,281
Previous 13,044 1.82%
Holding current value
$113,419
Previous $111,000 1.8%
% of portfolio
0.05%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
237 Added 1.82%
13,281 $113,000
Q2 2024

Aug 14, 2024

BUY
N/A
1,823 Added 16.25%
13,044 $111,000
Q1 2024

May 15, 2024

SELL
N/A
-771 Reduced 6.43%
11,221 $95,000
Q4 2023

Feb 15, 2024

SELL
N/A
-557 Reduced 4.44%
11,992 $102,000
Q3 2023

Nov 07, 2023

SELL
N/A
-1,250 Reduced 9.06%
12,549 $107,000
Q2 2023

Aug 14, 2023

BUY
$7.79 - $10.69 $29,259 - $40,151
3,756 Added 37.4%
13,799 $117,000
Q1 2023

May 15, 2023

SELL
$7.32 - $10.85 $28,203 - $41,805
-3,853 Reduced 27.73%
10,043 $99,000
Q4 2022

Feb 14, 2023

BUY
$7.84 - $11.68 $22,226 - $33,112
2,835 Added 25.63%
13,896 $111,000
Q3 2022

Nov 14, 2022

BUY
$10.73 - $20.07 $804 - $1,505
75 Added 0.68%
11,061 $119,000
Q2 2022

Aug 12, 2022

BUY
$6.76 - $14.18 $30,163 - $63,271
4,462 Added 68.39%
10,986 $119,000
Q1 2022

May 16, 2022

SELL
$11.13 - $23.04 $4,329 - $8,962
-389 Reduced 5.63%
6,524 $84,000
Q4 2021

Feb 14, 2022

BUY
$21.81 - $48.96 $32,147 - $72,167
1,474 Added 27.1%
6,913 $153,000
Q3 2021

Nov 15, 2021

SELL
$29.03 - $38.62 $8,273 - $11,006
-285 Reduced 4.98%
5,439 $162,000
Q2 2021

Aug 10, 2021

BUY
$32.29 - $39.68 $184,827 - $227,128
5,724 New
5,724 $218,000

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.